| Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibility S Chung, H Nakagawa, M Uemura, L Piao, K Ashikawa, N Hosono, ... Cancer science 102 (1), 245-252, 2011 | 380 | 2011 |
| Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer M Uemura, K Tamura, S Chung, S Honma, A Okuyama, Y Nakamura, ... Cancer science 99 (1), 81-86, 2008 | 309 | 2008 |
| Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism K Tamura, A Makino, F Hullin-Matsuda, T Kobayashi, M Furihata, ... Cancer research 69 (20), 8133-8140, 2009 | 232 | 2009 |
| A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population M Nakashima, S Chung, A Takahashi, N Kamatani, T Kawaguchi, ... Nature genetics 42 (9), 768-771, 2010 | 225 | 2010 |
| Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer S Chung, H Suzuki, T Miyamoto, N Takamatsu, A Tatsuguchi, K Ueda, ... Oncotarget 3 (12), 1629, 2012 | 170 | 2012 |
| Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin JH Park, T Katagiri, S Chung, K Kijima, Y Nakamura Neoplasia 13 (4), 320-IN10, 2011 | 106 | 2011 |
| EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth M Iiizumi, M Hosokawa, A Takehara, S Chung, T Nakamura, T Katagiri, ... Cancer science 97 (11), 1211-1216, 2006 | 91 | 2006 |
| Involvement of the tubulin tyrosine ligase-like family member 4 polyglutamylase in PELP1 polyglutamylation and chromatin remodeling in pancreatic cancer cells K Kashiwaya, H Nakagawa, M Hosokawa, Y Mochizuki, K Ueda, L Piao, ... Cancer research 70 (10), 4024-4033, 2010 | 67 | 2010 |
| Genome‐wide association study of chemotherapeutic agent‐induced severe neutropenia/leucopenia for patients in Biobank Japan SK Low, S Chung, A Takahashi, H Zembutsu, T Mushiroda, M Kubo, ... Cancer science 104 (8), 1074-1082, 2013 | 59 | 2013 |
| Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer H Inoue, T Kato, S Olugbile, K Tamura, S Chung, T Miyamoto, Y Matsuo, ... Oncotarget 7 (12), 13621, 2016 | 53 | 2016 |
| Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production S Chung, M Nakashima, H Zembutsu, Y Nakamura Proceedings of the Japan Academy, Series B 87 (8), 563-573, 2011 | 53 | 2011 |
| C12orf48, termed PARP‐1 binding protein, enhances poly (ADP‐ribose) polymerase‐1 (PARP‐1) activity and protects pancreatic cancer cells from DNA damage L Piao, H Nakagawa, K Ueda, S Chung, K Kashiwaya, H Eguchi, ... Genes, Chromosomes and Cancer 50 (1), 13-24, 2011 | 53 | 2011 |
| Pharmacoethnicity in paclitaxel-induced sensory peripheral neuropathy M Komatsu, HE Wheeler, S Chung, SK Low, C Wing, SM Delaney, ... Clinical Cancer Research 21 (19), 4337-4346, 2015 | 46 | 2015 |
| p53-independent p21 induction by MELK inhibition T Matsuda, T Kato, K Kiyotani, YE Tarhan, V Saloura, S Chung, K Ueda, ... Oncotarget 8 (35), 57938, 2017 | 45 | 2017 |
| Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways S Chung, M Furihata, K Tamura, M Uemura, Y Daigo, Y Nasu, T Miki, ... Oncogene 28 (32), 2849-2859, 2009 | 45 | 2009 |
| Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors M Nakakido, K Tamura, S Chung, K Ueda, R Fujii, K Kiyotani, ... International journal of oncology 49 (3), 868-876, 2016 | 40 | 2016 |
| A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients S Chung, SK Low, H Zembutsu, A Takahashi, M Kubo, M Sasa, ... Breast Cancer Research 15, 1-10, 2013 | 39 | 2013 |
| Overexpression of the potential kinase serine/threonine/tyrosine kinase 1 (STYK 1) in castration‐resistant prostate cancer S Chung, K Tamura, M Furihata, M Uemura, Y Daigo, Y Nasu, T Miki, ... Cancer science 100 (11), 2109-2114, 2009 | 39 | 2009 |
| MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells S Chung, Y Nakamura Cell cycle 12 (11), 1655-1656, 2013 | 37 | 2013 |
| Stemness and immune evasion conferred by the TDO2‐AHR pathway are associated with liver metastasis of colon cancer T Miyazaki, S Chung, H Sakai, H Ohata, Y Obata, D Shiokawa, ... Cancer science 113 (1), 170-181, 2022 | 32 | 2022 |
Yusuke NakamuraJFCR, University of Chicago, University of Tokyo, RIKEN, Cancer Institute, Univ. of Utah, Osaka Univ在 jfcr.or.jp 的电子邮件经过验证
